Finance

Lists
OBI:LON
Ondine Biomedical Inc
GBX 10.10
-10.22%
(-1.15) 1D
Sep 11, 12:56:49 PM GMT+1  ·   GBX
All symbols
SymbolPriceChange% Change
Generating top insights for OBI...
Open
GBX 11.06
High
GBX 11.50
Low
GBX 10.06
Mkt. cap
58.65M
Avg. vol.
640.32K
Volume
1.12M
52-wk high
GBX 16.00
52-wk low
GBX 7.50
EPS
-GBX 0.03
No. of employees
43
Open
GBX 11.06
High
GBX 11.50
Low
GBX 10.06
Mkt. cap
58.65M
Avg. vol.
640.32K
Volume
1.12M
52-wk high
GBX 16.00
52-wk low
GBX 7.50
EPS
-GBX 0.03
No. of employees
43
News stories
From web sources and news partners
About Ondine Biomedical Inc
CEO-
Employees43
Founded1996
HeadquartersVancouver, British Columbia, Canada
SectorMedical device
Websiteondinebio.com
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CAD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
506.50K
506.50K
816.50K
816.50K
Cost of goods sold
178.00K
178.00K
339.00K
339.00K
Cost of revenue
178.00K
178.00K
339.00K
339.00K
Research and development expenses
3.98M
3.98M
6.63M
6.63M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.47M
2.47M
2.45M
2.45M
Operating expense
6.59M
6.59M
9.20M
9.20M
Total operating expenses
6.77M
6.77M
9.54M
9.54M
Operating income
-6.26M
-6.26M
-8.72M
-8.72M
Other non operating income
6.50K
6.50K
26.50K
26.50K
EBT including unusual items
-6.28M
-6.28M
-8.48M
-8.48M
EBT excluding unusual items
-6.28M
-6.28M
-8.48M
-8.48M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-6.28M
-6.28M
-8.48M
-8.48M
Net profit margin
-1,239.78%
-1,239.78%
-1,038.46%
-1,038.46%
Earnings per share
-
-
-
-
Interest and investment income
93.00K
93.00K
90.00K
90.00K
Interest expense
-2.50K
-2.50K
-9.00K
-9.00K
Net interest expenses
90.50K
90.50K
81.00K
81.00K
Depreciation and amortization charges
141.00K
141.00K
120.00K
120.00K
EBITDA
-6.10M
-6.10M
-8.63M
-8.66M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps